Journal article
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
Andrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, Hugh D Falls, Michael J Mitten, Peter J DeVries, Lorenzo Benatuil, Chung-Ming Hsieh, Jonathan A Meulbroek, Sanjay C Panchal, Fritz G Buchanan, Kenneth R Durbin, Martin J Voorbach, David R Reuter, Sarah R Mudd, Lise I Loberg, Sherry L Ralston, Diana Cao, Hui K Gan, Andrew M Scott Show all
Molecular Cancer Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2018
Grants
Funding Acknowledgements
The design, conduct, and financial support for the study were provided by AbbVie.